Delivery Order SPE2DB24D2013-SPE2DB25FCHKA
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$68K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,823.00 Firm Fixed Price Delivery Order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,022.32 firm fixed-price delivery order is for DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,821.30 firm-fixed-price delivery order is for the supply of 4566307081 - DAPAGLIFLOZIN 5 MG TABLET 30S, a generic pharmaceutical product used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $4,300.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in diabetes management. The contract has an ultimate completion date of November 15, 2024 and is a Firm Fixed Price agreement. This award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $24,943.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566999548 DAPAGLIFLOZIN 10 MG TABLET 30S, a drug used for the treatment of diabetes. The contract has an ultimate completion date of January 22, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,773.51, is a Firm Fixed Price Delivery Order for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The contract is not designated as a set-aside award. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,918.93 firm fixed-price delivery order is for the supply of 4567012423 DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat type 2 diabetes. The award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with ID SPE2DX15D1022|SPE2DX25FVCHR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,678.74 firm fixed-price delivery order is for the supply of 4567273589 ! DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.18 firm fixed-price delivery order is for the supply of 4567279776 DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,006.48 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a drug used in the management of diabetes. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...